Clinical Evaluation: Tropical Fever Testing & Support
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Naval Supply Systems Command (NAVSUP) Fleet Logistics Center Sigonella – Naples (FLCSI-N), on behalf of Navy Medical Research Unit Europe, Africa, Central (NAMRU EURAFCENT), has issued a Pre-Solicitation Notice of Intent to award a sole source, firm-fixed price purchase order to the University of Ghana Medical Center (UMGC). This contract supports a clinical evaluation of the Xpert® tropical fever test on the GeneXpert® Edge X system. Interested parties believing they can meet the requirement must submit capability statements by April 9, 2026, 4:00 PM Central European Time (CET).
Opportunity Details
This acquisition is for a scientific study titled "258C2: Clinical Evaluation of the Xpert® tropical fever test on the GeneXpert® Edge X system using venous and capillary whole blood specimens." The Xpert® Tropical Fever test is an automated, multiplex real-time PCR assay for the qualitative identification of nucleic acids from various fever-causing pathogens, including Plasmodium species, Dengue virus, Zika virus, Chikungunya virus, and Leptospira species.
Scope of Work
The contractor, UMGC, shall provide all necessary personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and non-personal services to perform sample collection and testing for Protocol 258C2. Key tasks include:
- Collecting capillary and venous blood samples from approximately 100 patients suspected of Tropical Fever or with relevant travel/residence history.
- Performing on-site testing of capillary blood using the GeneXpert® Edge X and GXDX systems.
- Conducting laboratory analysis on a portion of venous blood samples.
- Performing Biofire Global Fever Panel comparator testing and discrepant analysis with bi-directional sequencing.
Contractor Requirements
Personnel must possess basic security clearance (U.S. citizen, host country permit, or U.S. Embassy clearance). The contractor must establish and implement methods for key control and provide specific personnel, including a Principal Investigator, Co-PIs, Site Administrator, Phlebotomists, Consenters, Medical Screeners, BioFire Operators, Data Entry Personnel, and Research Assistants. Adherence to applicable regulations, publications, manuals, local policies, and procedures, specifically Protocol 258C2, is mandatory.
Contract & Timeline
- Contract Type: Firm-Fixed Price Purchase Order (Sole Source)
- Duration: One (1) Base Year of 12 months, with one (1) 6-month option period.
- Place of Performance: University of Ghana Medical Centre in Ghana.
- Set-Aside: None (Sole Source)
- Capability Statements Due: April 9, 2026, 4:00 PM CET
- Published Date: March 26, 2026
Response Information
This is a notice of intent, not a request for competitive proposals. The Government will consider capability statements from responsible sources that believe they can meet the requirement. Responses must provide clear and convincing evidence and be submitted via email to the Point of Contact.
Point of Contact
Tricia Folts, Contracting Officer | patricia.r.folts.civ@us.navy.mil